HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Nanomedicine in oncology: Tiny particles, huge potential Jennifer Byrne
• Gap between in vitro, in vivo performance a key obstacle in nanomedicine research Jennifer Byrne
• ‘Striking’ racial disparities observed in surgical care of gastrointestinal tract cancer Ryan Lawrence
• Multidisciplinary strategy essential to reduce racial disparities in breast, lung cancer mortality Nicholas J. Petrelli, MD, FACS
• Allogeneic HSCT effective for high-risk acute lymphoblastic leukemia Mark Leiser
• AYA cancer survivors at higher risk for death due to second primary cancers Jennifer R. Southall
• Azithromycin timing, duration does not affect hematologic relapse after pediatric HSCT Mark Leiser
• Biosimilar comparable to trastuzumab in efficacy for breast cancer subset Jennifer R. Southall
• Bitter taste receptors may hold potential as chemotherapeutic targets Jennifer Byrne; Agnes Mistlberger-Reiner, PhD; Sofie Zehentner, MSc
• CAR-T effective, safe for certain patients with central nervous system-involved lymphoma Mark Leiser
• Choosing a career in medicine takes ‘a fair amount of flexibility,’ many mentors Talitha Bennett
• Decrease in cervical cancer rates may be linked to HPV screening, vaccination Ryan Lawrence
• Defibrotide effective for veno-occlusive disease after HSCT Mark Leiser
• Factors predict survival after immunotherapy combination for HNSCC Mark Leiser
• Fludarabine may improve outcomes in pediatric B-cell acute lymphoblastic leukemia Jennifer R. Southall
• Ibrutinib shows promise for children with chronic graft-versus-host disease Jennifer R. Southall
• Individuals with long COVID may be at greater risk for abnormal blood clotting Jennifer R. Southall
• Lifetime excess weight linked to colorectal cancer risk Ryan Lawrence
• Many male AYAs with sickle cell disease unaware of disease-related fertility issues Jennifer R. Southall
• Neoadjuvant chemoradiotherapy extends OS vs. upfront surgery in pancreatic cancer subsets Ryan Lawrence
• Neoadjuvant pembrolizumab does not increase surgical complications in oral cavity cancer Mark Leiser
• Outreach effort increases stem cell transplant referrals, may reduce racial disparities Mark Leiser
• Phase 3 trial of combination for advanced lung cancer misses co-primary endpoint
• Trial of combination for advanced melanoma fails to meet endpoints
• Regimen fails to extend PFS in small cell lung cancer
• Rilzabrutinib active, safe in immune thrombocytopenia Ryan Lawrence
• Rubraca extends PFS as maintenance therapy in ovarian cancer, topline data show
• Sickle cell disease increases risk for transplant-associated thrombotic microangiopathy Mark Leiser
• Surveillance testing, treatment may be overused in low-risk bladder cancer subgroup Ryan Lawrence
• Tobacco cessation program empowers patients at ‘teachable moment’ before cancer surgery Jennifer Byrne; Cary A. Presant, MD
• Treatment for HPV-positive oropharyngeal cancer varies by facility type Mark Leiser
• Uterine cancer mortality increases significantly, racial disparities appear multifactorial Jennifer R. Southall
• Zanubrutinib improves outcomes in chronic lymphocytic leukemia, small lymphocytic lymphoma Jennifer R. Southall
• American Cancer Society names chief scientific officer
• IU Simon Comprehensive Cancer Center joins National Comprehensive Cancer Network
• Oncology Nursing Foundation announces mentorship award recipient
• Sidney Kimmel Cancer Center — Jefferson Health names director
• Society honors leaders in transplantation, cellular therapy